investorscraft@gmail.com

Intrinsic ValueNomura Micro Science Co., Ltd. (6254.T)

Previous Close¥3,490.00
Intrinsic Value
Upside potential
Previous Close
¥3,490.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Nomura Micro Science Co., Ltd. is a specialized provider of advanced water treatment technologies, serving industries such as electronics, pharmaceuticals, biotechnology, and food production. The company designs, installs, and sells a comprehensive range of water treatment systems, including ultra-pure water production, wastewater treatment, and water reclamation solutions. Its product portfolio spans filtration, ion exchange, reverse osmosis, and monitoring systems, tailored to high-purity requirements in critical manufacturing processes. Operating primarily in Japan, South Korea, Taiwan, China, and the U.S., Nomura Micro Science has established itself as a trusted partner for industries demanding stringent water quality standards. The company’s expertise in pharmaceutical-grade water systems and semiconductor-grade ultra-pure water positions it as a niche leader in high-value industrial applications. Its integrated services, including water analysis and on-site supply, further enhance its value proposition in a market increasingly focused on sustainability and regulatory compliance. With a foundation dating back to 1969, the firm combines deep technical knowledge with long-term client relationships, reinforcing its competitive edge in a sector where reliability and precision are paramount.

Revenue Profitability And Efficiency

Nomura Micro Science reported revenue of JPY 73.0 billion for FY 2024, with net income of JPY 7.98 billion, reflecting a robust net margin of approximately 10.9%. The company’s diluted EPS stood at JPY 209.7, demonstrating strong earnings generation. However, operating cash flow was negative at JPY -18.7 billion, likely due to working capital adjustments or project timing, while capital expenditures remained modest at JPY -356 million, indicating efficient asset utilization.

Earnings Power And Capital Efficiency

The company’s earnings power is underscored by its JPY 7.98 billion net income, supported by its specialized market positioning. Capital efficiency appears balanced, with limited capex relative to revenue, suggesting a lean operational model. The negative operating cash flow warrants monitoring, but the firm’s profitability metrics remain healthy, with ROE likely elevated given its net income and equity base.

Balance Sheet And Financial Health

Nomura Micro Science holds JPY 12.1 billion in cash and equivalents against total debt of JPY 22.4 billion, indicating a manageable leverage position. The balance sheet reflects a focus on growth financing, with liquidity sufficient to cover near-term obligations. The debt level is moderate relative to its JPY 76.9 billion market cap, suggesting financial flexibility for strategic investments or cyclical downturns.

Growth Trends And Dividend Policy

The company’s growth is tied to demand for high-purity water systems in electronics and pharmaceuticals, sectors with steady expansion. Its dividend payout of JPY 80 per share signals a commitment to shareholder returns, with a yield likely competitive within its peer group. Future growth may hinge on geographic expansion and technological advancements in water treatment, particularly in emerging markets.

Valuation And Market Expectations

With a market cap of JPY 76.9 billion and a beta of 1.4, Nomura Micro Science trades with higher volatility than the broader market, reflecting its niche focus. Investors likely price in its expertise in high-margin water treatment solutions, though the negative operating cash flow may temper valuation multiples until clarity on cash conversion improves.

Strategic Advantages And Outlook

Nomura Micro Science’s deep industry expertise and diversified client base provide resilience against sector-specific downturns. Its focus on high-growth areas like semiconductor and pharmaceutical water systems positions it well for long-term demand. Challenges include managing working capital cycles and expanding in competitive international markets, but its technical differentiation and established reputation offer a solid foundation for sustained performance.

Sources

Company description, financial data from disclosed filings, and market data from exchange sources.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount